1-4 of 4
Niccolò Bartalucci, PhD
Close
Sort by
Journal Articles

Calreticulin Ins5 and Del52 Mutations Impair Unfolded Protein and Oxidative Stress Responses in Hematopoietic Cells

Simona Salati, PhD, Elena Genovese, BSc, Zelia Prudente, BSc, PhD, Chiara Carretta, Niccolò Bartalucci, PhD BSc, Valentina Pennucci, PhD, Samantha Ruberti, BSc, PhD, Chiara Rossi, PharmD, Sebastiano Rontauroli, BSc, Carmela Mannarelli, PhD, Roberta Zini, BSc, PhD, Elisa Bianchi, BSc, PhD, Paola Guglielmelli, MD PhD, Enrico Tagliafico, MDPhD, Alessandro M. Vannucchi, MD, Rossella Manfredini, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4332.
https://doi.org/10.1182/blood-2018-99-112550
Published: 2018
Journal Articles

Large Genomic Alterations Occurring in the Transition from Chronic to Blast Phase of Chronic Myeloproliferative Neoplasms

Niccolò Bartalucci, PhD BSc, Alberto Magi, PhD, Elisa Contini, PhD, Davide Bolognini, PhD, Simone Romagnoli, BSc, Paola Guglielmelli, MD PhD, Alessandro M. Vannucchi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3028.
https://doi.org/10.1182/blood-2018-99-113048
Published: 2018
Journal Articles

Complete Inhibition of STAT5 Phosphorylation Is Achieved By Combination of JAK1/2 and PI3K/mTOR Inhibitors in in Vitro and In Vivo MPN Models

Niccolò Bartalucci, PhD, Laura Calabresi, BiSci, Serena Martinelli, BiSci, Manjola Balliu, PhD, Jean-Luc Villeval, PhD, Francesco Annunziato, PhD, Alessandro M. Vannucchi
Journal: Blood
Blood (2015) 126 (23): 2824.
https://doi.org/10.1182/blood.V126.23.2824.2824
Published: 2015
Journal Articles

The PI3K Specific Inhibitor BKM120 Results Effective and Synergizes With Ruxolitinib In Preclinical Models Of Myeloproliferative Neoplasms

Niccolò Bartalucci, PhD, Costanza Bogani, PhD, Serena Martinelli, BiSci, Carmela Mannarelli, BiSci, Jean-Luc Villeval, PhD, Alessandro M. Vannucchi, MD
Journal: Blood
Blood (2013) 122 (21): 1599.
https://doi.org/10.1182/blood.V122.21.1599.1599
Published: 2013